Fidanacogene Elaparvovec for Hemophilia B — A Multiyear Follow-up Study

John E.J. Rasko

University of Sydney, Central Clinical School, Faculty of Medicine and Health, Sydney

Benjamin J. Samelson-Jones

Children’s Hospital of Philadelphia, Philadelphia

Lindsey A. George

Children’s Hospital of Philadelphia, Philadelphia

Adam Giermasz

Hemophilia Treatment Center, University of California, Davis, Sacramento

Jonathan M. Ducore

Hemophilia Treatment Center, University of California, Davis, Sacramento

Jerome M. Teitel

St. Michael’s Hospital, University of Toronto, Toronto

Catherine E. McGuinn

Weill Cornell Medicine, New York

Katherine A. High

Perelman School of Medicine at the University of Pennsylvania, Philadelphia

Ype P. de Jong

Laboratory of Virology and Infectious Disease, The Rockefeller University

Amit Chhabra

Pfizer, New York

Amanda O’Brien

Pfizer, Collegeville, PA

Lynne M. Smith

Pfizer, Collegeville, PA

Ian Winburn

Pfizer, Walton on the Hill, United Kingdom

Jeremy Rupon

Pfizer, Collegeville, PA